Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study

Androgen deprivation therapy (ADT) is used to improve overall survival (OS) in prostate cancer treatment; however, we encountered that long-term ADT in elderly patients may be related to high other-cause mortality (OCM). This study aimed to confirm the potential risk associated with long-term ADT in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Hideya, Masui, Koji, Suzuki, Gen, Aibe, Norihiro, Shimizu, Daisuke, Kimoto, Takuya, Yoshida, Ken, Nakamura, Satoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408941/
https://www.ncbi.nlm.nih.gov/pubmed/32698307
http://dx.doi.org/10.3390/jcm9072296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408941/
https://www.ncbi.nlm.nih.gov/pubmed/32698307
http://dx.doi.org/10.3390/jcm9072296

Ejemplares similares